Cannonball Kids’ cancer Foundation: Clinical Trial Grant
The Cannonball Kids’ cancer Foundation is accepting applications for its 2024 Clinical Trial Grant, designed to launch early-phase clinical trials offering novel treatment options for children with cancer. These trials must be innovative, impactful, and potentially practice-changing, aiming to expand the landscape of pediatric cancer therapies. The foundation encourages applications that emphasize early access to groundbreaking science for children who urgently need alternatives beyond standard care.
Supports cutting-edge, early-phase clinical trials aimed at introducing novel treatments and strategies for pediatric cancer. The goal is to increase options, improve outcomes, and provide hope for children with cancer.
Eligibility:
Open to investigators affiliated with U.S.-based institutions who are conducting clinical trials focused on pediatric cancers.
Funding Details:
-
Grant Amount: Up to 200,000 USD
-
Duration: 12 to 24 months
-
Funding may cover personnel, patient care costs, and essential trial operations.
Deadline:
-
Letter of Intent (LOI): Due June 7, 2024
-
Full Application (by invitation only): Due August 9, 2024
More Information:
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023